Literature DB >> 25165079

Severe sepsis due to Chryseobacterium indologenes in an immunocompetent adventure traveler.

Genevieve McKew1.   

Abstract

Chryseobacterium indologenes is an environmental organism which is usually an opportunistic pathogen, most usually associated with nosocomial or device-related infections. This case, affecting a fit and well adventure traveler, demonstrates that it may be an agent of severe sepsis in otherwise healthy humans.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Year:  2014        PMID： 25165079      PMCID： PMC4313263          DOI： 10.1128/JCM.01691-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  8 in total

1.  Cellulitis and bacteraemia due to Chryseobacterium indologenes.

Authors:  B T Green; P E Nolan
Journal:  J Infect       Date:  2001-04       Impact factor: 6.072

2.  Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan.

Authors:  P R Hsueh; L J Teng; P C Yang; S W Ho; W C Hsieh; K T Luh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-08       Impact factor: 3.267

3.  Exercise-associated hyponatraemia on the Kokoda Track.

Authors:  David A Pattison; Tomos E Walters; Eric Seal
Journal:  Med J Aust       Date:  2011-03-07       Impact factor: 7.738

4.  Clinical characteristics, antimicrobial susceptibilities, and outcomes of patients with Chryseobacterium indologenes bacteremia in an intensive care unit.

Authors:  Deng-Wei Chou; Shu-Ling Wu; Chao-Tai Lee; Fan-Ting Tai; Wen-Liang Yu
Journal:  Jpn J Infect Dis       Date:  2011       Impact factor: 1.362

5.  Clinical and microbiological characteristics of Chryseobacterium indologenes bacteremia.

Authors:  Yi-Tsung Lin; Yuan-Yu Jeng; Mei-Lin Lin; Kwok-Woon Yu; Fu-Der Wang; Cheng-Yi Liu
Journal:  J Microbiol Immunol Infect       Date:  2010-12       Impact factor: 4.399

6.  Relapsing vivax malaria despite chemoprophylaxis in two blood donors who had travelled to Papua New Guinea.

Authors:  Clive R Seed; Jacqueline T Coughlin; Anne M Pickworth; Robert J Harley; Anthony J Keller
Journal:  Med J Aust       Date:  2010-04-19       Impact factor: 7.738

7.  Chryseobacterium indologenes bacteraemia in a diabetic child.

Authors:  Antonio Cascio; Giovanna Stassi; Gaetano B Costa; Giuseppe Crisafulli; Immacolata Rulli; Caterina Ruggeri; Chiara Iaria
Journal:  J Med Microbiol       Date:  2005-07       Impact factor: 2.472

8.  [A severe form of Chryseobacterium indologenes pneumonia in an immunocompetent patient].

Authors:  I Reynaud; V Chanteperdrix; C Broux; P Pavese; J Croizé; M Maurin; J-P Stahl; C Jacquot
Journal:  Med Mal Infect       Date:  2007-09-20       Impact factor: 2.152
  8 in total
  3 in total

1.  Bacteremia by Chryseobacterium indologenes in a Patient with Lung Cancer: A Clinical and Microbiological Investigation.

Authors:  Gitali Bhagawati; Ashutosh Bhardwaj; Rekha Sajikumar; Sukhwinder Pal Singh; Sanjeev Prajapati
Journal:  Indian J Crit Care Med       Date:  2019-03

2.  Combining Citizen Science and Genomics to Investigate Tick, Pathogen, and Commensal Microbiome at Single-Tick Resolution.

Authors:  Gaurav Chauhan; Jesse McClure; Jessica Hekman; Patrick W Marsh; Jeffrey A Bailey; Rachel F Daniels; Diane P Genereux; Elinor K Karlsson
Journal:  Front Genet       Date:  2020-01-21       Impact factor: 4.599

3.  Chryseobacterium bacteraemia in a patient with heart failure: case report and literature review.

Authors:  Taylor Wood; Antonio Abbate; Inna Tchoukina; Michael P Stevens
Journal:  Eur Heart J Case Rep       Date:  2020-11-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.